HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carolyn F Deacon Selected Research

Hormones (Hormone)

1/2020Effects of Pioglitazone on Glucose-Dependent Insulinotropic Polypeptide-Mediated Insulin Secretion and Adipocyte Receptor Expression in Patients With Type 2 Diabetes.
9/2018Acute Effects of Dietary Carbohydrate Restriction on Glycemia, Lipemia and Appetite Regulating Hormones in Normal-Weight to Obese Subjects.
11/2017Elevated Postoperative Endogenous GLP-1 Levels Mediate Effects of Roux-en-Y Gastric Bypass on Neural Responsivity to Food Cues.
11/2016Feedback suppression of meal-induced glucagon-like peptide-1 (GLP-1) secretion mediated through elevations in intact GLP-1 caused by dipeptidyl peptidase-4 inhibition: a randomized, prospective comparison of sitagliptin and vildagliptin treatment.
8/2014Effects of sitagliptin on glycemia, incretin hormones, and antropyloroduodenal motility in response to intraduodenal glucose infusion in healthy lean and obese humans and patients with type 2 diabetes treated with or without metformin.
5/2012Impaired crosstalk between pulsatile insulin and glucagon secretion in prediabetic individuals.
1/2011Physiology of incretins in health and disease.
2/2010Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men.
1/2010Incretin hormone secretion over the day.
1/2009The incretin system and its role in type 2 diabetes mellitus.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carolyn F Deacon Research Topics

Disease

78Type 2 Diabetes Mellitus (MODY)
01/2023 - 05/2002
10Insulin Resistance
11/2022 - 08/2005
8Body Weight (Weight, Body)
11/2022 - 10/2002
8Hypoglycemia (Reactive Hypoglycemia)
01/2020 - 09/2004
7Obesity
09/2021 - 02/2010
7Hyperglycemia
01/2020 - 04/2009
6Weight Loss (Weight Reduction)
11/2022 - 09/2004
5Glucose Intolerance
04/2015 - 09/2004
4Heart Failure
10/2022 - 01/2018
3Overweight
11/2022 - 02/2011
2Metabolic Diseases (Metabolic Disease)
01/2019 - 10/2015
2Hyperlipidemias (Hyperlipidemia)
09/2018 - 01/2016
2Chronic Renal Insufficiency
01/2018 - 03/2004
2Diabetes Mellitus
04/2008 - 09/2006
2Weight Gain
01/2008 - 09/2004
1Bone Resorption
07/2023
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
07/2023
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021
1Cardiovascular Diseases (Cardiovascular Disease)
12/2018
1Kidney Diseases (Kidney Disease)
01/2018
1Pancreatitis
12/2016
1Glucagonoma
01/2016
1Hyperplasia
01/2016
1Chronic Kidney Failure (Chronic Renal Failure)
09/2014
1Inflammation (Inflammations)
09/2014
1Prediabetic State (Prediabetes)
03/2013
1Chronic Pancreatitis
01/2009
1Nausea
01/2009
1Diarrhea
01/2009
1Vomiting
01/2009

Drug/Important Bio-Agent (IBA)

50Glucose (Dextrose)FDA LinkGeneric
07/2023 - 12/2003
48Glucagon-Like Peptide 1 (GLP 1)IBA
10/2022 - 03/2004
28IncretinsIBA
01/2022 - 03/2004
22Insulin (Novolin)FDA Link
07/2023 - 04/2003
19Dipeptidyl-Peptidase IV InhibitorsIBA
11/2020 - 04/2005
17Hormones (Hormone)IBA
01/2020 - 11/2004
15Glucagon (Glukagon)FDA Link
11/2022 - 01/2007
13Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
01/2016 - 05/2002
11Peptides (Polypeptides)IBA
01/2023 - 03/2004
11VildagliptinIBA
12/2016 - 01/2007
8Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA
01/2022 - 12/2003
8Metformin (Glucophage)FDA LinkGeneric
10/2020 - 01/2006
8Sitagliptin Phosphate (Januvia)FDA Link
01/2018 - 11/2006
7EnzymesIBA
01/2020 - 06/2004
6Blood Glucose (Blood Sugar)IBA
01/2021 - 09/2004
5C-PeptideIBA
07/2023 - 05/2003
5Glucagon-Like Peptide-1 Receptor AgonistsIBA
12/2016 - 09/2007
5Hypoglycemic Agents (Hypoglycemics)IBA
04/2011 - 09/2004
4LiraglutideFDA Link
11/2022 - 10/2002
4Glucagon-Like Peptides (Enteroglucagon)IBA
05/2022 - 03/2012
4Proteins (Proteins, Gene)FDA Link
09/2018 - 04/2016
4Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA
11/2016 - 01/2008
3Glucagon-Like Peptide-1 ReceptorIBA
11/2022 - 01/2016
3LinagliptinIBA
01/2022 - 01/2010
3CarbohydratesIBA
10/2020 - 01/2018
3Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA
01/2018 - 03/2012
2Neprilysin (Neutral Endopeptidase)IBA
10/2022 - 09/2021
2sacubitril and valsartan sodium hydrate drug combinationIBA
10/2022 - 09/2021
2Triglycerides (Triacylglycerol)IBA
05/2022 - 12/2018
2XanthineIBA
11/2012 - 01/2010
2Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
04/2011 - 05/2009
1Procollagen Type IIBA
07/2023
1Collagen Type I (Type I Collagen)IBA
07/2023
1Alanine (L-Alanine)FDA Link
11/2022
1Angiotensin Receptor AntagonistsIBA
10/2022
1Pancreatic HormonesIBA
10/2022
1Lipoproteins (Lipoprotein)IBA
05/2022
1Peptide Hydrolases (Proteases)FDA Link
09/2021
1SodiumIBA
01/2021
1Pioglitazone (Actos)FDA Link
01/2020
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2019
1Vasodilator Agents (Vasodilators)IBA
01/2019
1Fatty Acids (Saturated Fatty Acids)IBA
12/2018
1Nonesterified Fatty Acids (NEFA)IBA
12/2018
1Dietary Carbohydrates (Carbohydrate, Dietary)IBA
09/2018
1Cholecystokinin (Pancreozymin)IBA
09/2018
1Lipase (Acid Lipase)FDA Link
12/2016
1AmylasesFDA Link
12/2016
1OxyntomodulinIBA
05/2016
1Amino AcidsFDA Link
01/2016
1Therapeutic UsesIBA
01/2016
1exendin (9-39)IBA
01/2016
1Glucagon Receptors (Glucagon Receptor)IBA
01/2016
1AtropineFDA LinkGeneric
09/2015
1Cell Adhesion MoleculesIBA
09/2014
1Arginine (L-Arginine)FDA Link
04/2013
1Prednisolone (Predate)FDA LinkGeneric
04/2013
1GlucocorticoidsIBA
04/2013
1Chlorogenic AcidIBA
02/2011
1CoffeeFDA Link
02/2011
1trigonellineIBA
02/2011
1saxagliptinFDA Link
05/2009

Therapy/Procedure

11Therapeutics
01/2018 - 12/2004
4Intravenous Infusions
01/2018 - 12/2003
4Gastric Bypass (Roux-en-Y Gastric Bypass)
11/2017 - 09/2014
3Aftercare (After-Treatment)
01/2022 - 07/2007
3Glycemic Control
11/2012 - 02/2008
2High-Protein Diet
10/2020 - 01/2018
2Oral Administration
01/2018 - 01/2007
1Vagotomy
09/2014